Approaches To Indication-Based Pricing For Cancer Drugs Offered In JAMA Article
Executive Summary
In most cases, application of the approaches would lead to a reduction in price, sometimes substantially, according to a set of hypothetical scenarios developed by author Peter Bach of Memorial Sloan Kettering.